Bone marrow findings and examination of peripheral blood CD20 cells in late-onset neutropenia after rituximab administration for nephrotic syndrome-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Bone marrow findings and examination of peripheral blood CD20 cells in late-onset neutropenia after rituximab administration for nephrotic syndrome

Published:2020 Issue:1 Volume:33 Page:51-57
ISSN:0915-2245
Container-title:Japanese journal of pediatric nephrology
language:en
Short-container-title:Nihon Shoni Jinzobyo Gakkai Zasshi

Author:

Kurata Satoko¹,Tanaka Seiji¹,Hiyoshi Yusuke¹,Araki Junichiro¹,Esaki Takuya¹,Zaitsu Ayuko¹,Komatsu Nobukazu²,Hisano Satoshi³

Affiliation:

1. Department of Pediatrics and Child Health, Kurume University School of Medicine

2. Department of Immunology, Kurume University School of Medicine

3. Department of Pathology and Cell Biology, School of Medicine, University of Occupational and Environmental Health

Publisher

Japanese Society for Pediatric Nephrology

Subject

Literature and Literary Theory,History,Cultural Studies

Link

https://www.jstage.jst.go.jp/article/jjpn/33/1/33_cr.2019.0160/_pdf

Reference14 articles.

1. 1) Coiffier B: Rituximab therapy in malignant lymphoma. Oncogene 2007; 26: 3603–3613.

2. 2) van Oers MH, Klasa R, Marcus RE, Wolf M, Kimby E, Gascoyne RD, Jack A, Van’t Veer M, Vranovsky A, Holte H, van Glabbeke M, Teodorovic I, Rozewicz C, Hagenbeek A: Rituximab maintenance improves clinical outcome of relapsed/resistant follicular non-Hodgkin lymphoma in patients both with and without rituximab during induction: results of a prospective randomized phase 3 intergroup trial. Blood 2006; 108: 3295–3301.

3. 3) Salmon JH, Cacoub P, Combe B, Sibilia J, Pallot-Prades B, Fain O, Cantagrel A,Dougados M, Andres E, Meyer O, Carli P, Pertuiset E, Pane I, Maurier F, Ravaud P,Mariette X, Gottenberg JE: Late-onset neutropenia after treatment with rituximab for rheumatoid arthritis and other autoimmune diseases: data from the AutoImmunity and Rituximab registry. RMD Open 2015; 1: e000034. doi: 10.1136/rmdopen-2014-000034.

4. 4) Jones RB, Ferraro AJ, Chaudhry AN, Brogan P, Salama AD, Smith KG, Savage CO, Jayne DR: A multicenter survey of rituximab therapy for refractory antineutrophil cytoplasmic antibody-associated vasculitis. Arthritis Rheum 2009; 60: 2156–2168.

5. 6) Iijima K, Sako M, Nozu K: Rituximab treatment for nephrotic syndrome in children. Curr Pediatr Rep 2015; 3: 71–77.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3